Read More

Evoke Pharma Has Priced An Underwritten Public Offering Led By Nantahala Capital Management For Gross Proceeds Of Up To $30M Million, Which Includes Initial Upfront Funding Of Approximately $7.5M

The offering is comprised of (i) 11,029,411 shares of common stock (or pre-funded warrants in lieu thereof), (ii) 11,029,411 Series A Warrants with an initial exercise price of $0.68 per share and a term of

EVOK

Read More

‘NYCB In Talks To Offload Mortgage Risk, Plans To Sell RV Loans; Bank Considers A Credit-Risk Transfer Backed By Mortgages; Regional Lender’s Shares Have Plunged On Real Estate Concerns’ – Bloomberg News

https://www.bloomberg.com/news/articles/2024-02-07/nycb-in-talks-to-offload-mortgage-risk-plans-to-sell-rv-loansNew York Community Bancorp has been reaching out to investors for capital to finance a large portfolio of

NYCB